Shanghai Kaibao Pharmaceutical (300039) — Free Cash Flow Generation Index
Shanghai Kaibao Pharmaceutical (300039) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of CN¥187.61 Million represents 1% of operating cash flow (CN¥190.98 Million). Read 300039 total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Kaibao Pharmaceutical Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Shanghai Kaibao Pharmaceutical across 19 annual periods. Explore Shanghai Kaibao Pharmaceutical capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Shanghai Kaibao Pharmaceutical (2006–2024)
Year-by-year Free Cash Flow Generation Index for Shanghai Kaibao Pharmaceutical. For the full company profile including market capitalisation, see Shanghai Kaibao Pharmaceutical (300039) total market value.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | CN¥138.43 Million | CN¥278.95 Million | CN¥140.52 Million | ▼ -46.3% |
| 2023 | 0.92x | CN¥353.59 Million | CN¥382.66 Million | CN¥29.08 Million | ▲ +0.9% |
| 2022 | 0.92x | CN¥344.80 Million | CN¥376.42 Million | CN¥31.62 Million | ▲ +38.3% |
| 2021 | 0.66x | CN¥83.53 Million | CN¥126.08 Million | CN¥42.55 Million | ▼ -29.8% |
| 2020 | 0.94x | CN¥236.71 Million | CN¥250.65 Million | CN¥13.94 Million | ▼ -1.0% |
| 2019 | 0.95x | CN¥318.63 Million | CN¥334.09 Million | CN¥15.46 Million | ▲ +5.9% |
| 2018 | 0.90x | CN¥236.29 Million | CN¥262.36 Million | CN¥26.07 Million | ▲ +12.6% |
| 2017 | 0.80x | CN¥196.51 Million | CN¥245.76 Million | CN¥49.24 Million | ▼ -12.5% |
| 2016 | 0.91x | CN¥287.85 Million | CN¥314.88 Million | CN¥27.03 Million | ▲ +8.1% |
| 2015 | 0.85x | CN¥276.68 Million | CN¥327.08 Million | CN¥50.40 Million | ▲ +11.8% |
| 2014 | 0.76x | CN¥213.64 Million | CN¥282.38 Million | CN¥68.74 Million | ▲ +34.6% |
| 2013 | 0.56x | CN¥151.95 Million | CN¥270.23 Million | CN¥118.28 Million | ▼ -28.4% |
| 2012 | 0.79x | CN¥191.12 Million | CN¥243.32 Million | CN¥52.21 Million | ▲ +162.1% |
| 2011 | 0.30x | CN¥29.46 Million | CN¥98.31 Million | CN¥68.85 Million | ▲ +119.0% |
| 2010 | -1.58x | CN¥-31.22 Million | CN¥19.79 Million | CN¥51.01 Million | ▼ -14.0% |
| 2009 | -1.38x | CN¥-72.97 Million | CN¥52.74 Million | CN¥125.70 Million | ▼ -449.0% |
| 2008 | 0.40x | CN¥7.41 Million | CN¥18.70 Million | CN¥11.28 Million | ▼ -50.5% |
| 2007 | 0.80x | CN¥18.65 Million | CN¥23.27 Million | CN¥4.62 Million | ▲ +98.3% |
| 2006 | 0.40x | CN¥7.96 Million | CN¥19.70 Million | CN¥11.74 Million | — |